Burian M - Search Results

1

Pharmacological and histopathological characterization of a hyperalgesia model induced by freeze lesion.

Schmidtko A, Burian M, Altis K, Hardt K, Angioni C, Schmidt R, Podda M, Geisslinger G. Schmidtko A, et al. Among authors: burian m. Pain. 2007 Feb;127(3):287-295. doi: 10.1016/j.pain.2006.11.002. Epub 2006 Dec 26. Pain. 2007. PMID: 17189672 Clinical Trial.

2

[Clinical pharmacology of the selective COX-2 inhibitors].

Burian M, Geisslinger G. Burian M, et al. Orthopade. 2003 Dec;32(12):1078-87. doi: 10.1007/s00132-003-0569-0. Orthopade. 2003. PMID: 14655004 Review. German.

3

Peripheral opioid analgesia in experimental human pain models.

Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, Lötsch J. Tegeder I, et al. Among authors: burian m. Brain. 2003 May;126(Pt 5):1092-102. doi: 10.1093/brain/awg115. Brain. 2003. PMID: 12690049 Clinical Trial.

4

Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain.

Burian M, Tegeder I, Seegel M, Geisslinger G. Burian M, et al. Clin Pharmacol Ther. 2003 Aug;74(2):113-20. doi: 10.1016/S0009-9236(03)00165-6. Clin Pharmacol Ther. 2003. PMID: 12891221 Clinical Trial.

5

COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites.

Burian M, Geisslinger G. Burian M, et al. Pharmacol Ther. 2005 Aug;107(2):139-54. doi: 10.1016/j.pharmthera.2005.02.004. Epub 2005 Apr 19. Pharmacol Ther. 2005. PMID: 15993252 Review.

6

Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population.

Burian M, Grösch S, Tegeder I, Geisslinger G. Burian M, et al. Br J Clin Pharmacol. 2002 Nov;54(5):518-21. doi: 10.1046/j.1365-2125.2002.01693.x. Br J Clin Pharmacol. 2002. PMID: 12445031 Free PMC article.

7

Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.

Alsalameh S, Burian M, Mahr G, Woodcock BG, Geisslinger G. Alsalameh S, et al. Among authors: burian m. Aliment Pharmacol Ther. 2003 Feb 15;17(4):489-501. doi: 10.1046/j.1365-2036.2003.01460.x. Aliment Pharmacol Ther. 2003. PMID: 12622757 Review.

8

Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.

Burian M, Neumann T, Weber M, Brandt R, Geisslinger G, Mitrovic V, Hamm C. Burian M, et al. Int J Clin Pharmacol Ther. 2006 Mar;44(3):107-12. doi: 10.5414/cpp44107. Int J Clin Pharmacol Ther. 2006. PMID: 16550732

9

Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system.

Weber M, Burian M, Dragutinovic I, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C, Geisslinger G. Weber M, et al. Among authors: burian m. Eur J Heart Fail. 2008 May;10(5):482-9. doi: 10.1016/j.ejheart.2008.03.009. Epub 2008 Apr 24. Eur J Heart Fail. 2008. PMID: 18436476 Free article.

10

Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.

Burian M, Piske M, Petkovic D, Mitrovic V. Burian M, et al. Cardiovasc Drugs Ther. 2004 Jan;18(1):37-46. doi: 10.1023/B:CARD.0000025754.08942.03. Cardiovasc Drugs Ther. 2004. PMID: 15115902 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters